Etanercept therapy in patients with autoimmunity and hepatitis C

M. Khanna, M. A. Shirodkar, A. B. Gottlieb

Research output: Contribution to journalArticlepeer-review

45 Scopus citations


Accumulated data suggest that etanercept may be a therapeutic option in patients with hepatitis C and coexisting autoimmune disorders such as rheumatoid arthritis, psoriasis, psoriatic arthritis and ankylosing spondylitis. Additionally, etanercept may actually be of benefit, when used in combination with standard treatments, for hepatitis C.

Original languageEnglish
Pages (from-to)229-232
Number of pages4
JournalJournal of Dermatological Treatment
Issue number4
StatePublished - Dec 2003
Externally publishedYes


  • Etanercept
  • Hepatitis C
  • Infliximab
  • Psoriasis
  • Psoriatic arthritis
  • TNF


Dive into the research topics of 'Etanercept therapy in patients with autoimmunity and hepatitis C'. Together they form a unique fingerprint.

Cite this